B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Sealing of the nuclear envelope (NE) by ESCRT-III

REACTOME PATHWAY
Reactome: R-HSA-966832817 genes9 compounds

The Sealing of the nuclear envelope (NE) by ESCRT-III pathway (Reactome ID: R-HSA-9668328) involves 17 genes and is affected by 9 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBA8TUBAL3TUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TUBB8B

Compounds Affecting Sealing of the nuclear envelope (NE) by ESCRT-III

#CompoundTargets HitStudies
1Colchicine300
2Nocodazole Nocodazole is215
3Vincristine299
4Noscapine300
5Podophyllotoxin14
6Demecolcine246
7Maytansine300
8vinblastine sulfate81
9Vorinostat299

About the Sealing of the nuclear envelope (NE) by ESCRT-III Pathway

The Sealing of the nuclear envelope (NE) by ESCRT-III pathway is catalogued in Reactome (ID: R-HSA-9668328) and involves 17 genes. In the BiohacksAI corpus, 9 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3E.